戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  control of cholesterol biosynthesis for CNS myelinogenesis.
2 rescues MBP expression from the beginning of myelinogenesis.
3  reduced in the qkV/qkV mutant during normal myelinogenesis.
4  indicating the essential function of QKI in myelinogenesis.
5 ecifically in myelinating glia during active myelinogenesis.
6 rapid accumulation of MBP mRNA during active myelinogenesis.
7 tegrin receptor signaling may be involved in myelinogenesis.
8 l patterns of oligodendrocyte generation and myelinogenesis.
9 roliferation and (2) delay maturation and/or myelinogenesis.
10 a central role in brain VLCFA metabolism and myelinogenesis.
11 regulator of myelin membrane trafficking and myelinogenesis.
12 vity and proteolipid protein function during myelinogenesis.
13  of mature oligodendrocytes during postnatal myelinogenesis.
14 fic miRNA-regulated checkpoints that control myelinogenesis and a therapeutic role for miR-219 in CNS
15 tes with Sox10 to regulate the initiation of myelinogenesis and acts as a molecular nexus of regulato
16 ts crucial for axon-glial recognition during myelinogenesis and axon-myelin stability.
17 n in mice of both sexes results in defective myelinogenesis and remyelination.
18 ogression, its molecular targets involved in myelinogenesis are mostly unidentified.
19 ecular mechanisms underlying oligodendrocyte myelinogenesis are poorly defined.
20 ights the significance of PLP1 dosage in CNS myelinogenesis as well as the importance of accurate det
21 OR and SOX10 co-occupy enhancers of critical myelinogenesis-associated genes including Prr18, encodin
22 n pathways, active during specific phases of myelinogenesis for regulating myelin formation, remain p
23 itical for Schwann cell (SC) development and myelinogenesis in a manner dependent on transmembrane ty
24  promoting accelerated MBP expression during myelinogenesis in a MBP isoform-preferential manner, and
25 g1 is a central regulator of oligodendrocyte myelinogenesis in brain and that axonal recognition and
26 nscription factor, Olig1, in oligodendrocyte myelinogenesis in brain development.
27 liferation of purified OLP in culture and on myelinogenesis in cerebellar slices.
28  which to modulate their differentiation and myelinogenesis in vivo following transplantation.
29  models of demyelination and enables de novo myelinogenesis on regenerated CNS axons.
30 rapping of that membrane around axons during myelinogenesis, or to stabilize the myelin spiral that f
31  attenuated during the most active period of myelinogenesis (P13 and P20).
32  molecular mechanisms for Fyn to control CNS myelinogenesis remain elusive.
33 d axons suggests that NT-3- and BDNF-induced myelinogenesis resulted, at least in part, from expansio
34  pivotal roles to advance OL development and myelinogenesis through Akt/mTOR activation.
35    This peptide may normally function during myelinogenesis to detect conformational changes originat
36 scent exercise intervention, a stimulator of myelinogenesis, to upregulate corpus callosum myelinatio
37 gests a novel mechanism for accelerating CNS myelinogenesis via regulating mRNA metabolism.
38               To determine whether augmented myelinogenesis was associated with increased proliferati
39 f apoptotic cells during the later stages of myelinogenesis were observed.
40            Oligodendrocytes (OLs) engaged in myelinogenesis were selectively vulnerable, in contrast